These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24657270)

  • 1. Weight variation over time and its relevance among multidrug-resistant tuberculosis patients.
    Chung-Delgado K; Revilla-Montag A; Guillén-Bravo S; Bernabe-Ortiz A
    Int J Infect Dis; 2014 Jun; 23():20-4. PubMed ID: 24657270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
    Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
    Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
    Chavez Pachas AM; Blank R; Smith Fawzi MC; Bayona J; Becerra MC; Mitnick CD
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis.
    Kang YA; Kim SY; Jo KW; Kim HJ; Park SK; Kim TH; Kim EK; Lee KM; Lee SS; Park JS; Koh WJ; Kim DY; Shim TS
    Respiration; 2013; 86(6):472-8. PubMed ID: 23689646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007.
    Bang D; Lillebaek T; Thomsen VØ; Andersen AB
    Scand J Infect Dis; 2010 Apr; 42(4):288-93. PubMed ID: 20082573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis in household contacts of multidrug-resistant tuberculosis patients.
    Grandjean L; Crossa A; Gilman RH; Herrera C; Bonilla C; Jave O; Cabrera JL; Martin L; Escombe AR; Moore DA
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1164-9, i. PubMed ID: 21943839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru.
    Otero L; De Orbegoso A; Navarro AF; Ríos J; Párraga T; Gotuzzo E; Seas C; Van der Stuyft P
    Trop Med Int Health; 2015 Mar; 20(3):322-5. PubMed ID: 25429916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.
    Baghaei P; Tabarsi P; Dorriz D; Marjani M; Shamaei M; Pooramiri MV; Mansouri D; Farnia P; Masjedi M; Velayati A
    Am J Ther; 2011; 18(2):e29-34. PubMed ID: 20019591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
    Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
    Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon].
    Marica C; Didilescu C; Chiotan D; Galie N; Tănăsescu M; Popescu-Hagen M; Popa M
    Pneumologia; 2008; 57(4):195-200. PubMed ID: 19186681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening outcomes from patients with suspected multidrug-resistant tuberculosis: lessons learned in the Philippines.
    Gler MT; Guilatco RS; Guray CV; Tupasi TE
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1326-30. PubMed ID: 22863522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis.
    Shin SS; Hyson AM; Castañeda C; Sánchez E; Alcántara F; Mitnick CD; Fawzi MC; Bayona J; Farmer PE; Kim JY; Furin JJ
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):347-53. PubMed ID: 12729340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.
    Mitnick C; Bayona J; Palacios E; Shin S; Furin J; Alcántara F; Sánchez E; Sarria M; Becerra M; Fawzi MC; Kapiga S; Neuberg D; Maguire JH; Kim JY; Farmer P
    N Engl J Med; 2003 Jan; 348(2):119-28. PubMed ID: 12519922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002.
    Shean KP; Willcox PA; Siwendu SN; Laserson KF; Gross L; Kammerer S; Wells CD; Holtz TH
    Int J Tuberc Lung Dis; 2008 Oct; 12(10):1182-9. PubMed ID: 18812049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis in children exposed at home to multidrug-resistant tuberculosis.
    Becerra MC; Franke MF; Appleton SC; Joseph JK; Bayona J; Atwood SS; Mitnick CD
    Pediatr Infect Dis J; 2013 Feb; 32(2):115-9. PubMed ID: 22926210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
    Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary resection for multidrug-resistant tuberculosis: the Israeli experience (1998-2011).
    Papiashvili M; Barmd I; Sasson L; Lidji M; Litman K; Hendler A; Polanski V; Treizer L; Bendayan D
    Isr Med Assoc J; 2012 Dec; 14(12):733-6. PubMed ID: 23393710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.